Here in Boston, we fret about losing tech talent and leadership to the West Coast. So today, let’s celebrate the return of one of our own. Michael Schreck has joined Boston-based digital publishing firm Zmags as its new CEO, as of earlier this month. Schreck, a prominent investor and entrepreneur, has spent the past eight … Continue reading “Michael Schreck Back in Boston as New Zmags CEO; Digital Publishing Firm Shifts to Commerce”
Category: Boston
BioBehavioral Diagnostics Lands $500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=91cdf68c-8f88-4f53-80b6-2832a70e438f&Preview=1 Date 5/24/2011 Company Name BioBehavioral Diagnostics Mailing Address 239 Littleton Road Westford, MA 01886 Company Description BioBehavioral Diagnostics Company (BioBDx) is a privately held company whose mission is to develop, manufacture, and market proprietary diagnostic systems for the quantitative assessment of behavioral disorders, including the measurement of medication response and the … Continue reading “BioBehavioral Diagnostics Lands $500,000 New Funding Round”
Gtrot Secures Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea2dd473-a88b-488e-9d47-3d431ce2dd0a&Preview=1 Date 5/24/2011 Company Name Gtrot Mailing Address 67 Mount Auburn St. Fourth Floor Cambridge, MA 02138 Company Description The company operates an online social oriented travel site. Website http://www.gtrot.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Gtrot Secures Series A Financing”
AutoVirt Garners $5,015,213 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=304b1f24-887a-4535-8aaa-68f43d198213&Preview=1 Date 5/24/2011 Company Name AutoVirt Mailing Address 12 Murphy Drive Nashua, NH 03062 Company Description AutoVirt’s mission is to increase IT productivity by replacing manual labor with automation and virtualization. Virtualization separates the purpose and benefit of a service from its physical implementation and is often the key to greater automation. … Continue reading “AutoVirt Garners $5,015,213 New Funding Round”
Crimson Hexagon Secures $5,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bc246735-d06a-4d50-9527-74f66ced5548&Preview=1 Date 5/24/2011 Company Name Crimson Hexagon Mailing Address 130 Bishop Allen Drive Cambridge, MA 02139 Company Description Understand what the online conversation really means for your brand. Our VoxTrot Listening Platform distills meaning — with mathematical precision — from the cloudy torrent of opinion, information and data available online. Website http://www.crimsonhexagon.com … Continue reading “Crimson Hexagon Secures $5,000,000 Series B Funding”
Harvest Power Receives $6,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6833efe6-869e-4466-b065-d378d9f3e15d&Preview=1 Date 5/24/2011 Company Name Harvest Power Mailing Address 610 Lincoln St 3rd Floor Waltham, MA 02451 Company Description Harvest’s superpowered products and capabilities give us the opportunity to create a new life-cycle for organics. We assist communities with source separation programs, build renewable energy facilities and utilize our best-in-class technologies to … Continue reading “Harvest Power Receives $6,000,000 Series B Financing Round”
Radius Health Obtains $91,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b60d3a0f-47cb-45a1-a210-d8db4b93c86a&Preview=1 Date 5/24/2011 Company Name Radius Health Mailing Address 300 Technology Square Fifth Floor Cambridge, MA 02139 Company Description Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. Website http://www.radiuspharm.com Transaction Type Debt, Venture Equity Transaction Amount $91,000,000 Transaction … Continue reading “Radius Health Obtains $91,000,000 New Funding”
QD Vision Receives $22,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1fc76e3f-3499-420d-95cb-632ba3a445c2&Preview=1 Date 5/24/2011 Company Name QD Vision Mailing Address 313 Pleasant St Watertown, MA 02472 Company Description Our leading edge solutions will give customers decisive performance and manufacturing advantages in the competitive market for flat panel displays. Because our solutions use standard OLED device structures, customers with installed manufacturing equipment can leverage … Continue reading “QD Vision Receives $22,000,000 New Funding”
CaseNET Secures $3,255,153 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6d5c8c12-e972-4b29-bce2-7f31df61a529&Preview=1 Date 5/24/2011 Company Name CaseNET Mailing Address 23 Crosby Drive Bedford, MA 01730 Company Description The company is a developer of care management software for workers’ compensation and health care organizations. Website http://www.casenetinc.com Transaction Type Venture Equity Transaction Amount $3,255,153 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC … Continue reading “CaseNET Secures $3,255,153 New Funding”
IPO Pipeline Pumps Up the Volume in First Quarter
A recent study of IPO filings by the Ernst & Young accounting firm shows that 47 companies filed for initial public offerings during the quarter that ended March 31, and a total of 125 companies are waiting to go public on U.S. markets. Of the 125 companies in the pipeline, 25 are based in California, … Continue reading “IPO Pipeline Pumps Up the Volume in First Quarter”
Mass Tech Hub State House Day
This event, put on by the state’s Joint Committee on Economic Development & Emerging Technologies, will take a deep dive into the importance of the digital and IT sectors in Massachusetts. Entrepreneurs and legislators will gather at this one. Check this site out for more info.
Web Innovators Group 30
Check out the June version of the WebInno series of events. A crop of companies—which will soon be announced—in the mobile and Web IT spaces will present to the audience and showcase on the sidelines. There will be plenty of networking, too, at this event, which you can register for here.
Mass Innovation Nights #27
Four products—as voted by prospective audience members—will demo at this 27th installment of Mass Innovation Nights. Check out the crop of contenders in the Web and IT space, and sign up for the Westborough event here
Gates Funds MIT’s Liquid Metal Battery
Liquid Metal Battery, an MIT spinout that is building a battery made of liquid-state cathode, anode, and electrolyte components, has nabbed a seed investment from Bill Gates and an undisclosed oil driller, CNET reports. The aim is to cut the cost of energy storage and enable batteries to store hours of wind and solar power, … Continue reading “Gates Funds MIT’s Liquid Metal Battery”
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug
[Update: 12:03 pm ET, with pricing info] Vertex’s big day has arrived. The Cambridge, MA-based biotech company has gotten clearance from the FDA to start marketing telaprevir (Incivek) as a new treatment for patients in the U.S. with hepatitis C. The new drug, a protease inhibitor designed to fight the liver-damaging virus, is now approved … Continue reading “Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug”
BzzAgent Bought by Tesco’s Dunnhumby, Brings Social Marketing Expertise to Retail Giant
Boston social-marketing company BzzAgent said today it is being acquired by U.K.-based consumer analytics firm Dunnhumby, a subsidiary of retail giant Tesco. Terms were not disclosed, but various media reports put the acquisition price at $60 million, contingent on BzzAgent hitting certain milestones. BzzAgent started in 2001 and has amassed a network of 800,000 consumer … Continue reading “BzzAgent Bought by Tesco’s Dunnhumby, Brings Social Marketing Expertise to Retail Giant”
Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy
[Correction: 10:22 am 5/24/11] Bluebird Bio is one of those fortunate companies that can say the top peer-reviewed journals in biomedical research—Science and Nature—have run articles featuring its two lead drug candidates while they are still at the earliest phase of development. CEO Nick Leschly doesn’t want to sound ungrateful—the buzz doesn’t hurt—but he seems … Continue reading “Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy”
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired
Most biotech entrepreneurs I’ve met have a dream that ends one of two ways. They will either take their company public, or sell their startup to a giant drugmaker. Those are the paths to making money, making venture investors happy, and getting the resources needed to take a new drug all the way to the … Continue reading “How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired”
Dunnhumby Acquires BzzAgent for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9e8262b9-80ae-49d8-a1c0-b9437244114a&Preview=1 Date 5/23/2011 Company Name BzzAgent Mailing Address 500 Harrison Avenue Boston, MA 02118 Company Description BzzAgent, Inc. is a word-of-mouth marketing and media company that enables companies to organize and manage honest, real-world conversations between everyday consumers. BzzAgent’s innovative process and platform allows it to develop systemized campaigns that help accelerate … Continue reading “Dunnhumby Acquires BzzAgent for Undisclosed Sum”
Explosive Market Growth: LivingSocial CEO Tim O’Shaughnessy and a Discussion of Online-to-Offline Commerce With Demos
The hottest area of retail these days might be so-called online-to-offline sales, as represented by companies such as Groupon and rival LivingSocial. Founded in 2007, LivingSocial now claims 85 million users, and reportedly takes in more than $50M in monthly revenue. LivingSocial CEO Tim O’Shaughnessy chats with North Bridge Ventures’ Dayna Grayson is this MIT … Continue reading “Explosive Market Growth: LivingSocial CEO Tim O’Shaughnessy and a Discussion of Online-to-Offline Commerce With Demos”
Kareem Abdul-Jabbar Gives Lift to Skyhook Wireless By Following CEO Ted Morgan on Twitter
If you’re a loyal reader of Xconomy, and have followed stories such as VC Varsity, you know we aren’t above finding a sports angle to our coverage of the innovation community. Skyhook Wireless is no exception. The company was founded by Ted Morgan and Michael Shean and named in part because of their love of … Continue reading “Kareem Abdul-Jabbar Gives Lift to Skyhook Wireless By Following CEO Ted Morgan on Twitter”
Garageband on the iPad Makes Amateur Musicians into Artists
Can you be a composer without being a musician? Thanks to the latest generation of music authoring software, the answer is yes. Take me, for example. I played the trombone in high school, and I can still read music (bass clef anyway), but I would be very hard pressed to strum a guitar chord, keep … Continue reading “Garageband on the iPad Makes Amateur Musicians into Artists”
Mobile Startup Session M Emerges with $6.5M from Highland, KPCB
Interesting news in the mobile scene today. Session M, a new Boston-area startup, announced it has raised $6.5 million in Series A financing from Highland Capital Partners, Kleiner Perkins Caufield & Byers (iFund), and mobile industry leaders. Bob Davis from Highland and Matt Murphy from KPCB serve on the company’s board. As is often the … Continue reading “Mobile Startup Session M Emerges with $6.5M from Highland, KPCB”
Biogen Gets EU Panel OK for MS Drug
Weston, MA-based Biogen Idec (NASDAQ: [[ticker:BIIB]]) said today that it has received a positive opinion from a committee of the European Medicines Agency, which should pave the way to begin sales in Europe of fampridine (Fampyra) as a new treatment for multiple sclerosis. Based on the committee recommendation, Biogen Idec said it expects to be … Continue reading “Biogen Gets EU Panel OK for MS Drug”
ImmunoGen Grabs $84M
Waltham, MA-based ImmunoGen (NASDAQ: [[ticker:IMGN]]), the developer of targeted antibody drugs for cancer, said today it has raised $84 million through a stock offering. The company sold 7 million new shares at $12 apiece. Jefferies & Co., Oppenheimer & Co., RBC Capital Markets, William Blair & Co., Canaccord Genuity and Morgan Joseph TriArtisan managed the … Continue reading “ImmunoGen Grabs $84M”
DataXu, Recent Investment in Tow, Helps Brands Follow Consumers as More Ads Go Digital
Here’s a quick snapshot of a local tech company that lots of people talk about, but not usually in much depth. Probably because it focuses on helping online advertisers understand consumers, but it’s not for consumers. Boston-based DataXu has been growing fast over the past year, and now has offices in Boston, New York, San … Continue reading “DataXu, Recent Investment in Tow, Helps Brands Follow Consumers as More Ads Go Digital”
PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News
We saw news on both the drugs and medical devices sides of the life sciences industry in New England this week. —PerkinElmer (NYSE: [[ticker:PKI]]), a Waltham, MA-based provider of life sciences tools, said it acquired Labtronics, an Ontario, Canada-based provider of electronic laboratory notebook products. Deal terms weren’t disclosed. —Two-year-old Foundation Medicine of Boston revealed it … Continue reading “PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News”
Session M Garners $6,500,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eef25000-896c-4711-8fce-068ab8d1205e&Preview=1 Date 5/20/2011 Company Name Session M Mailing Address Undisclosed Boston, MA 02421 Company Description The company is developing a mobile application to deliver rewarding experiences to its users. Website http://www.sessionm.com Transaction Type Venture Equity Transaction Amount $6,500,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. The company is … Continue reading “Session M Garners $6,500,000 Series A Funding Round”
Report: AstraZeneca to Lay Off 135 in MA
U.K.-based drug giant AstraZeneca (NYSE: [[ticker:AZN]]) is planning to lay off 135 employees at its facility in Westborough, MA, starting at the end of May and continuing through the end of 2011. The news was reported today by the Boston Business Journal, which cites a notice to state labor officials. The Westborough plant, which makes … Continue reading “Report: AstraZeneca to Lay Off 135 in MA”
Thermo Pays $3.5B for Phadia
Waltham, MA-based Thermo Fisher Scientific (NASDAQ: [[ticker:TMO]]), a provider of products and services for labs, announced that it has acquired Sweden-based Phadia from the European private equity firm Cinven for about $3.5 billion in cash. The acquisition of Phadia, which provides allergy and autoimmunity diagnostic products, is expected to close fourth quarter 2011 and will … Continue reading “Thermo Pays $3.5B for Phadia”
Boston Venture Firms on the Move: A Roundup of Who’s Heading West (to CA), and Who’s Heading East (to Cambridge)
Updated, see below—The January 2009 announcement by Y Combinator that it was leaving the Boston area and moving full-time to Silicon Valley gave a real jolt to the local innovation community. Then, only a few months later, Greylock Partners dropped a similar bombshell. The storied venture firm, arguably in the elite of the elite alongside … Continue reading “Boston Venture Firms on the Move: A Roundup of Who’s Heading West (to CA), and Who’s Heading East (to Cambridge)”
TechStars Boston Alum Sensobi Joins Forces With GroupMe To Better Organize Mobile Social Network
Mobile app developer Sensobi reaped the benefits of the tight-knit New York tech startup community earlier this month, you could say. CEO and founder Ajay Kulkarni calls it “a fortuitous introduction that turned into something bigger.” That would be Sensobi’s acquisition by GroupMe. Sensobi, which I profiled last January, offers a $10 BlackBerry app that … Continue reading “TechStars Boston Alum Sensobi Joins Forces With GroupMe To Better Organize Mobile Social Network”
VGo Brings in $4.3M
VGo Communications, a Nashua, NH-based robotics startup, has pulled in $4.3 million of a targeted $6 million offering, an SEC filing showed. The money comes from 11 investors. VGo, formerly known as North End Technologies, makes devices for two-way, audio and visual conferencing, to better connect employees of the same company at different locations. The company … Continue reading “VGo Brings in $4.3M”
Medtronic’s Hawkins and BSX’s Elliott Exit Stage Right As Medical Device Industry Shifts
It’s pretty tough to be a CEO at a major medical device company these days. Just ask Bill Hawkins, who was reportedly pushed out at Medtronic and Ray Elliott, who abruptly left Boston Scientific. I’m not sure if the two men ever knew each other but their departures have a weird type of symmetry. Both … Continue reading “Medtronic’s Hawkins and BSX’s Elliott Exit Stage Right As Medical Device Industry Shifts”
Wherefore Art Thou Angels? Boston Startup Scene Gears Up for Angel Bootcamp on June 14 (and Wants a Little More Froth)
Yes, I’m well aware that “wherefore” means “for what reason.” In this case, the reasons for being an active angel investor in Boston have to do with being part of a bigger and collaborative ecosystem, giving back to the startup community, and helping create the future of technology. It’s exciting stuff—especially in this day and … Continue reading “Wherefore Art Thou Angels? Boston Startup Scene Gears Up for Angel Bootcamp on June 14 (and Wants a Little More Froth)”
Celldex Raises $31.5M, Stock Drops
Needham, MA-based Celldex Therapeutics (NASDAQ: [[ticker:CLDX]]) said today it has raised $31.5 million through a stock offering. The company sold 10 million shares at $3.15 apiece, roughly a 19 percent discount to yesterday’s closing stock price of $3.88, before the deal was announced. Jefferies & Co, Wedbush Securities, Brean Murray, Carret & Co. and Roth … Continue reading “Celldex Raises $31.5M, Stock Drops”
SiGe Opts for $275M Acquisition Instead of IPO
Andover, MA-based SiGe Semiconductor, which first revealed its plans to go public last July, is instead set to be acquired by another Bay State semiconductor technology company, Skyworks (NASDAQ: [[ticker:SWKS]]). Woburn, MA-based Skyworks, whose analog and mixed signal semiconductors have applications in the military, medical, broadband, mobile, industrial, automotive, and energy management spaces, will pay as … Continue reading “SiGe Opts for $275M Acquisition Instead of IPO”
Innovation as King Is Dead. The Day of the Innovator Has Arrived
[This post was co-authored by Joseph Steig of VentureWell—Eds.] The United States needs new, bold science innovation to address the challenges facing people and the planet—and to create jobs and a strong economy. Yet what is glamorous in popular business culture is not science innovation, but rather bold pitches, business innovations, fast and big exits. … Continue reading “Innovation as King Is Dead. The Day of the Innovator Has Arrived”
Should Biology Go Open Source? Join the Debate June 16 With Phil Sharp and Stephen Friend
Biology has long been based on a model in which scientists think up a dynamite experiment, gather data, keep it all close to the vest, and publish the (hoped-for) blockbuster results in a top peer-reviewed journal. Like many biologists, MIT’s Phil Sharp made his name following this time-honored method for discovering and disseminating knowledge. Now … Continue reading “Should Biology Go Open Source? Join the Debate June 16 With Phil Sharp and Stephen Friend”
Carbonite Files for IPO, Autonomy Pays $380M for Iron Mountain Businesses, PerkinElmer Buys Labtronics, & More Boston-Area Deals News
We saw a mix of funding and acquisition news for New England’s tech and life sciences startups this week. —Carbonite, a Boston-based online data backup firm, revealed it was planning to go public. The company, which has raised more than $67 million in venture capital, didn’t yet say how many shares it will be offering … Continue reading “Carbonite Files for IPO, Autonomy Pays $380M for Iron Mountain Businesses, PerkinElmer Buys Labtronics, & More Boston-Area Deals News”
TurningArt Obtains $750,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=030afc7c-0150-437c-9dbd-3b5713dd992f&Preview=1 Date 5/18/2011 Company Name TurningArt Mailing Address 359 Green Street Cambridge, MA 02139 Company Description The company operates a website that allows users to rent by your exchange artworks. Website http://www.turningart.com Transaction Type Venture Equity Transaction Amount $750,000 Transaction Round Undisclosed Proceeds Purposes This new round of funding will be used … Continue reading “TurningArt Obtains $750,000 New Round”
Tepha Lands $4,970,273 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e90a6393-4d61-4213-b399-d08b14b7cce9&Preview=1 Date 5/18/2011 Company Name Tepha Mailing Address 99 Hayden Avenue East Wing Lexington, MA 02421 Company Description Tepha is a medical device firm engaged in the development of a new range of absorbable devices for therapeutic applications. Website http://www.tepha.com Transaction Type Venture Equity Transaction Amount $4,970,273 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Tepha Lands $4,970,273 New Round”
From Kendall Square to Kenya: What’s Hot in Mobile
All my peers in tech seem to be talking about wireless these days. So this past Friday, I stepped outside my world of the data biz to attend the MassTLC tech event on “The Global Impact of Mobility” at the Kendall Square Marriott next to MIT. The event included panelists from industry (Groupon, BT, Cisco, … Continue reading “From Kendall Square to Kenya: What’s Hot in Mobile”
Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry
Merck isn’t messing around with its new hepatitis C drug. It has now enlisted a powerhouse partner in its bid to fight for market share against Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: [[ticker:VRTX]]). The Whitehouse Station, NJ-based pharma giant (NYSE: [[ticker:MRK]]) said today that it has formed a non-exclusive alliance with Roche’s Genentech unit to help … Continue reading “Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry”
SciFluor Kicks Off With $5M
SciFluor Life Sciences, a Boston-based developer of technology for adding fluorine to organic molecules such as pharmaceutical drugs and commercial chemicals, launched today with $5 million in funding from Allied Minds. The technology, which helps make molecules more stable, potent, and better able to penetrate the blood-brain barrier, comes from Harvard University’s professor Tobias Ritter … Continue reading “SciFluor Kicks Off With $5M”
Microsoft’s Qi Lu Talks Future of the Web: Look Out, Facebook, Groupon, Apple, and (Oh Yeah) Google
If Microsoft has its way, you’ll soon be Skyping on your Windows Phone with 500 of your closest Facebook friends about the latest daily deals in your city. Then you’ll find those local businesses through Bing, which will help you decide which ones to pursue—and will help both merchants and consumers cash in on those … Continue reading “Microsoft’s Qi Lu Talks Future of the Web: Look Out, Facebook, Groupon, Apple, and (Oh Yeah) Google”
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments
Boston-based Foundation Medicine has only been around for about two years, but it’s already making friends in big places. Today the company—which is developing advanced cancer diagnostics—announced a collaboration with Celgene (NASDAQ: [[ticker:CELG]]), based in Summit, NJ. Celgene plans to use Foundation Medicine’s genomics testing technology in trials of cancer drugs, in the hopes of … Continue reading “Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments”
VGo Communications Obtains $4,255,949 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b30242db-5da6-4f42-8f01-3fd915f27256&Preview=1 Date 5/17/2011 Company Name VGo Communications Mailing Address 100 Innovative Way Nashua, NH 03062 Company Description VGo Communications, Inc. develops and markets visual communications solutions for the workplace. Website http://www.vgocom.com Transaction Type Venture Equity Transaction Amount $4,255,949 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A … Continue reading “VGo Communications Obtains $4,255,949 New Round”
Shire Pharmaceuticals Acquires Advanced Biohealing for $750,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4650777-0196-4594-87f9-f33de8065b2c&Preview=1 Date 5/17/2011 Company Name Advanced Biohealing Mailing Address 36 Church Ln. Westport, CT 06880 Company Description Advanced BioHealing (ABH) is a specialty biotechnology company focused on the development and marketing of cell-based and tissue-engineered products for wound care. We are a privately held company with two approved products: Dermagraft and TransCyte. … Continue reading “Shire Pharmaceuticals Acquires Advanced Biohealing for $750,000,000”
PerkinElmer Buys Labtronics
Waltham, MA-based PerkinElmer (NYSE: [[ticker:PKI]]), a maker of tools for the life sciences field, announced today that it has bought Ontario, Canada-based Labtronics for an undisclosed sum. Labtronics provides electronic laboratory notebook products enabling laboratory routine analysis. Earlier this month PerkinElmer acquired Geospiza, a Seattle-based maker of software for DNA analysis.